Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series

Vaccination with Bacillus Calmette–Guérin (BCG) can be harmful to patients with combined primary immunodeficiencies. We report the outcome of BCG vaccination in a series of twelve patients affected by adenosine deaminase deficiency (ADA-SCID). BCG vaccination resulted in a very high incidence of com...

Descripción completa

Detalles Bibliográficos
Autores principales: Canarutto, Daniele, Oltolini, Chiara, Barzaghi, Federica, Calbi, Valeria, Migliavacca, Maddalena, Tucci, Francesca, Gallo, Vera, Consiglieri, Giulia, Ferrua, Francesca, Recupero, Salvatore, Cervi, Maria Celia, Al-Mousa, Hamoud, Pituch-Noworolska, Anna, Tassan Din, Chiara, Scarpellini, Paolo, Silvani, Paolo, Fossati, Claudia, Casiraghi, Miriam, Cirillo, Daniela Maria, Castagna, Antonella, Bernardo, Maria Ester, Aiuti, Alessandro, Cicalese, Maria Pia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376767/
https://www.ncbi.nlm.nih.gov/pubmed/37509449
http://dx.doi.org/10.3390/biomedicines11071809
Descripción
Sumario:Vaccination with Bacillus Calmette–Guérin (BCG) can be harmful to patients with combined primary immunodeficiencies. We report the outcome of BCG vaccination in a series of twelve patients affected by adenosine deaminase deficiency (ADA-SCID). BCG vaccination resulted in a very high incidence of complications due to uncontrolled replication of the mycobacterium. All patients who developed BCG-related disease were treated successfully and remained free from recurrence of disease. We recommend the prompt initiation of enzyme replacement therapy and secondary prophylaxis to reduce the risk of BCG-related complications in ADA-SCID patients.

Ejemplares similares